text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

请选择数量

A Ceramide-Trafficking Protein (CERT) Inhibitor

No.171(October 2016)
H1553
HPA-12 (1)
HPA-12 (1) is a ceramide (Cer) -trafficking inhibitor that was first discovered and synthesized by Hanada and Kobayashi et al.1,2) Ceramide is synthesized in the endoplasmic reticulum (ER) and is transported to the Golgi apparatus,3,4) where it is converted to sphingomyelin, by means of the ceramide transport protein (CERT).5) 1 inhibits the CERT, and has been used as a CERT inhibitor in various biological science studies.6) For example, 1 possesses antiviral and antibacterial properties against the growth of hepatitis C virus (HCV) and the obligate intracellular bacteria Chlamydiae in cultured human cells.6a,d,e) In addition, the CERT inhibition results in resensitization of cancer cells to chemotherapeutic agents such as paclitaxel.6b) Therefore, the inhibition of CERT may represent medical strategies, such as anti-infective and anticancer chemotherapy.
The product is for research purpose only.

References

Related Compounds

P1632
Paclitaxel
The prices are subject to change without notice. Please confirm the newest price by our online catalog before placing an order.
In addition, sales products changes with areas. Please understand that a product is not available when the product details page is not displayed.
會話狀態
當前會話將在10分鐘後超時,並返回主頁。請點擊按鈕繼續瀏覽。分鐘後超時,並返回主頁。請點擊按鈕繼續瀏覽。

您的會話已超時,將返回至主頁。